Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles
Yu-Nan Man, Mao-Lin He · 2026
Read Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles by Yu-Nan Man, Mao-Lin He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13313179.txt.
Description
Yu-Nan Man and Mao-Lin He review what is known about SEC61G in a 2026 paper. SEC61G is a small part of the Sec61 channel that moves new proteins into the cell. Once seen as a mere extra copy made beside the EGFR gene, it now looks like a driver of growth in many kinds of cancer.
The review sorts its cancer roles into three groups. One is control of immune checkpoints. Another is faulty calcium signals. The third covers paths that do not use the channel at all. It maps where SEC61G runs high across cancers and which tumors depend on it most, with cervical cancer standing out on both counts. The authors weigh drugs that block the channel pore against newer plans such as degraders. They back SEC61G as a marker for outlook and for response to immune therapy.
Catalog record
| CREATOR | Yu-Nan Man, Mao-Lin He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62898 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |